The structure of hepatitis B envelope and molecular variants of hepatitis B virus.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 7489342)

Published in J Viral Hepat on January 01, 1995

Authors

C R Howard1

Author Affiliations

1: Department of Pathology and Infectious Diseases, Royal Veterinary College, London, UK.

Articles citing this

Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev (1999) 2.55

Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J Clin Microbiol (2004) 1.12

A population-based study to investigate host genetic factors associated with hepatitis B infection and pathogenesis in the Chinese population. BMC Infect Dis (2008) 1.00

Serologic and molecular characteristics of hepatitis B virus among school children in East Java, Indonesia. Am J Trop Med Hyg (2010) 1.00

Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J Clin Microbiol (1999) 0.99

Hepatitis B virus mutations related to liver disease progression of Korean patients. World J Gastroenterol (2014) 0.91

Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol (2003) 0.91

Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection. J Virol (2000) 0.90

Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients. J Clin Microbiol (2015) 0.81

Mutations in the major hydrophilic region (MHR) of hepatitis B virus genotype C in North China. J Med Virol (2012) 0.79

In vivo hepatitis B virus-neutralizing activity of an anti-HBsAg humanized antibody in chimpanzees. Exp Mol Med (2008) 0.77

Dual oncogenic and tumor suppressor roles of the promyelocytic leukemia gene in hepatocarcinogenesis associated with hepatitis B virus surface antigen. Oncotarget (2016) 0.75

Factors associated with the decrease in hepatitis B surface antigen titers following interferon therapy in patients with chronic hepatitis B: Is interferon and adefovir combination therapy effective? Biomed Rep (2017) 0.75